当前位置:Public Access >页面
Chinese/English
Injection of fiblyzyme to treat acute ischemic stroke after listing effectiveness and safety randomization, blind method, placebo parallel control, multi-center clinical trials

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR2100042526

研究题目:

Injection of fiblyzyme to treat acute ischemic stroke after listing effectiveness and safety randomization, blind method, placebo parallel control, multi-center clinical trials

Study title:

Injection of fiblyzyme to treat acute ischemic stroke after listing effectiveness and safety randomization, blind method, placebo parallel control, multi-center clinical trials

 注册状况:

 Registration:

False

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

18980601670

电子邮件

Email

heli2003new@126.com

通讯地址:

#37 Guoxue Xiang, Chengdu, China

Address:

#37 Guoxue Xiang, Chengdu, China

邮政编码

Postcode

610000

项目负责人所有单位:

四川大学华西医院

Institution:

West China Hospital of Sichuan University

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理委员会

Name of the ethic committee:

Biomedical Ethics Committee of West China Hospital

研究疾病:

Study Ailment:

研究所处阶段:

Study phase:

研究类型:

Type of Study:

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

省(直辖市):

市(区县):

Country/Area:

Province:

City:

单位
Institution

预计起止时间:

Planned Duration:

2021-01-20 17:14:34-2021-01-20 17:14:34